Veeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this provider of cloud-based software services for the life sciences industry have returned +5.9% over the past month versus the Zacks S&P 500 composite's +1.1% change. The Zacks Internet - Software industry, to which Veeva belongs, has lost 6.4% over this period. Now the key question is: Where could ...

PLEASANTON, Calif., July 25, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today revealed that targeted pre-launch scientific outreach maximizes medical affairs teams' impact on treatment adoption in the latest Veeva Pulse Field Trends Report. The analysis shows biopharmas investing in pre-launch scientific activities and prioritizing congresses gain 40% faster treatment adoption than those that invested less. Earlycareer experts are also more open to digital engagement and four times more likely to start ...

BARCELONA, Spain, July 25, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Neuraxpharm will use Veeva Vault QualityDocs and Veeva Vault Training to advance its quality operations. Veeva quality applications will help Neuraxpharm achieve greater oversight and inspection readiness, while improving collaboration across its network of over 100 contract development and manufacturing organizations (CDMOs). Neuraxpharm is a pharmaceutical leader in disorders affecting the central nervous syste ...

Boston Scientific, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 12.5%. BSX's earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 7.5%. Boston Scientific's shares have rallied 46.3% against the industry's 1.8% decline in the past year. Veeva Systems Inc. (VEEV) recently announced that it is partnering with Vita Global Sciences. The partnership aims to modernize the latter's clinical data management processes and improve colla ...

In the latest market close, Veeva Systems (VEEV) reached $180.43, with a -0.82% movement compared to the previous day. This change lagged the S&P 500's 0.78% loss on the day. On the other hand, the Dow registered a loss of 1.29%, and the technology-centric Nasdaq decreased by 0.7%. The investment community will be paying close attention to the earnings performance of Veeva Systems in its upcoming release. The company is predicted to post an EPS of $1.53, indicating a 26.45% growth compared to the equivalent ...

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. What are the Zacks Style Scores? Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, an ...

Veeva Systems Inc. (VEEV) is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism led by a solid first-quarter fiscal 2025 performance and strategic deals are expected to contribute further. Stiff competition and data security threats persist. Image Source: Zacks Investment Research Over the past year, this Zacks Rank #3 (Hold) stock has lost 9.2% against 20.8% growth of the industry and a 25.1% rise of the S&P 500 Composite. In the first quarter of fiscal 20 ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Score ...

Veeva System (VEEV) recently announced a partnership with Vita Global Sciences that will help the latter to improve its clinical data management processes as well as collaboration with key trial stakeholders. Industry Prospects Per a report by Introspective Market Research, the global clinical data management system market is expected to grow from $2.3 billion in 2022 to $5.42 billion by 2030 at a growth rate of 11.3%. Factors like the rising number of clinical trials and the integration with other healthca ...

Veeva Forward-looking Statements SOURCE Veeva Systems About Veeva Systems The CRO will use Vault EDC to design and deliver complex studies for its sponsor clients. Looking ahead, Vita Global Sciences plans to add Veeva Clinical Database (CDB) to aggregate and clean data from all sources, and Veeva RTSM to randomize patients and optimize trial supply management. This ensures Vita Global Sciences can run the study clients want while gaining visibility and control of trial data. With modern clinical data manag ...